Structures by: Manoj K.
Total: 39
4-O-TOSYL 2,6-O-DIACETYL MYO-INOSITOL 1,3,5 ORTHOFORMATE
C18H20O10S
CrystEngComm (2009) 11, 6 1022
a=16.4270(17)Å b=6.1377(6)Å c=19.2741(19)Å
α=90.00° β=91.317(2)° γ=90.00°
6-O-TOSYL 2,4-O-DIACETYL MYO-INOSITOL 1,3,5 ORTHOFORMATE
C18H20O10S
CrystEngComm (2009) 11, 6 1022
a=6.206(2)Å b=14.602(5)Å c=42.099(13)Å
α=90.00° β=90.00° γ=90.00°
6-O-TOSYL 4,2-DI-O-ACETYL MYO-INOSITOL ORTHOACETATE
C19H22O10S
CrystEngComm (2009) 11, 6 1022
a=6.2596(8)Å b=9.8947(12)Å c=17.022(2)Å
α=87.723(2)° β=89.460(2)° γ=76.195(2)°
6-O-TOSYL 4,2-DI-O-ACETYL MYO-INOSITOL ORTHOACETATE
C19H22O10S
CrystEngComm (2009) 11, 6 1022
a=9.2713(11)Å b=35.728(4)Å c=6.1772(8)Å
α=90.00° β=90.872(2)° γ=90.00°
6(4)-O-CAMPHORSULFONYL 1,2,3,4(6),5-O-PENTA ACETYL MYO-INOSITOL
C26H36O14S,CH3NO2,0.25(H2O)
CrystEngComm (2012) 14, 5 1716
a=12.401(4)Å b=12.587(4)Å c=13.250(4)Å
α=98.697(5)° β=108.729(5)° γ=117.919(4)°
6(4)-O-CAMPHORSULFONYL 1,2,3,4(6),5-O-PENTA ACETYL MYO-INOSITOL
C26H36O14S,CH2Cl2
CrystEngComm (2012) 14, 5 1716
a=13.463(2)Å b=14.451(3)Å c=17.848(3)Å
α=90.00° β=91.363(3)° γ=90.00°
6(4)-O-CAMPHORSULFONYL 1,2,3,4(6),5-O-PENTA ACETYL MYO-INOSITOL
C26H36O14S,C2H4cl2
CrystEngComm (2012) 14, 5 1716
a=13.39(2)Å b=14.35(3)Å c=17.54(3)Å
α=90.00° β=91.55(2)° γ=90.00°
6(4)-O-CAMPHORSULPHONYL 1,2,3,4(6),5-O-PENTA ACETYL MYO-INOSITOL
C26H36O14S,0.25(CH2Cl2)
CrystEngComm (2012) 14, 5 1716
a=11.499(5)Å b=11.793(5)Å c=12.374(5)Å
α=94.564(7)° β=101.799(7)° γ=105.126(7)°
6(4)-O-CAMPHORSULFONYL 1,2,3,4(6),5-O-PENTA ACETYL MYO-INOSITOL
C26H36O14S,C2H3N,0.5(H2O)
CrystEngComm (2012) 14, 5 1716
a=12.404(4)Å b=12.492(4)Å c=13.331(4)Å
α=99.188(5)° β=109.620(5)° γ=116.837(4)°
1,2,3,4(6),5-O-PENTA ACETYL 6(4)-O-CAMPHORSULFONYL MYO-INOSITOL
C26H36O14S,0.75(C3H6O)
CrystEngComm (2012) 14, 5 1716
a=13.597(4)Å b=14.351(4)Å c=17.818(5)Å
α=90.00° β=91.466(5)° γ=90.00°
6(4)-O-CAMPHORSULFONYL 1,2,3,4(6),5-O-PENTA ACETYL MYO-INOSITOL
C26H36O14S,0.75(CHCl3)
CrystEngComm (2012) 14, 5 1716
a=13.857(3)Å b=14.298(3)Å c=17.717(4)Å
α=90.00° β=90.651(4)° γ=90.00°
C14H14O3,0.5(C10H8N2)
C14H14O3,0.5(C10H8N2)
CrystEngComm (2014) 16, 26 5811
a=7.624(6)Å b=5.800(4)Å c=36.02(3)Å
α=90.00° β=90.017(8)° γ=90.00°
RS-Naproxen-Piperidine
C14H13O3,0.5(C4H10N2)
CrystEngComm (2014) 16, 26 5811
a=7.966(4)Å b=6.012(3)Å c=28.985(15)Å
α=90.00° β=91.739(7)° γ=90.00°
2(C14H14O3),C10H8N2
2(C14H14O3),C10H8N2
CrystEngComm (2014) 16, 26 5811
a=15.206(6)Å b=5.766(2)Å c=19.370(8)Å
α=90.00° β=111.189(5)° γ=90.00°
S-Naproxen-Piperidine
2(C14H13O3),C4H10N2
CrystEngComm (2014) 16, 26 5811
a=8.029(4)Å b=6.118(3)Å c=28.045(14)Å
α=90.00° β=93.990(7)° γ=90.00°
C15H18N2O4
C15H18N2O4
Acta Crystallographica Section B (2020) 76, 5
a=12.7410(4)Å b=7.7542(3)Å c=29.3961(11)Å
α=90° β=98.6000(10)° γ=90°
C15H18N2O4
C15H18N2O4
Acta Crystallographica Section B (2020) 76, 5
a=7.3324(9)Å b=29.277(3)Å c=7.4171(8)Å
α=90° β=117.402(4)° γ=90°
C15H18N2O4
C15H18N2O4
Acta Crystallographica Section B (2020) 76, 5
a=7.1190(2)Å b=7.2678(3)Å c=15.0171(6)Å
α=78.0120(10)° β=82.1820(10)° γ=66.0070(10)°
C15H18N2O4
C15H18N2O4
Acta Crystallographica Section B (2020) 76, 5
a=7.3901(5)Å b=25.1748(18)Å c=8.0438(6)Å
α=90° β=108.992(3)° γ=90°
C15H18N2O4
C15H18N2O4
Acta Crystallographica Section B (2020) 76, 5
a=13.1277(19)Å b=13.977(2)Å c=17.802(3)Å
α=80.629(5)° β=82.485(5)° γ=62.419(5)°
4,6-di-O-benzyl-myo-inositol 1,3,5-orthoformate
C21H22O6
Acta Crystallographica Section C (2005) 61, 11 o628-o630
a=9.0511(11)Å b=10.0953(12)Å c=10.6586(13)Å
α=68.849(2)° β=81.453(2)° γ=87.433(2)°
4,6-di-<i>O</i>-acetyl-2-<i>O</i>-tosyl-<i>myo</i>-inositol 1,3,5-orthoformate
C18H20O10S
Acta Crystallographica Section C (2009) 65, 7 o335-o338
a=8.5756(6)Å b=11.0381(8)Å c=11.2005(8)Å
α=100.4260(10)° β=103.1230(10)° γ=99.6600(10)°
4,6-di-<i>O</i>-acetyl-2-<i>O</i>-tosyl-<i>myo</i>-inositol 1,3,5-orthobenzoate
C24H24O10S
Acta Crystallographica Section C (2009) 65, 7 o335-o338
a=12.3019(14)Å b=8.2155(10)Å c=23.551(3)Å
α=90.00° β=91.306(2)° γ=90.00°
2,4(6)-di-O-benzoyl-6(4)-O-{[(1S)-7,7-dimethyl-2- oxobicyclo[2.2.1]heptan-1-ylmethyl]sulfonyl}-myo-inositol 1,3,5-orthoacetate
C32H34O11S
Acta Crystallographica Section C (2007) 63, 9 o555-o558
a=11.5241(16)Å b=11.6958(16)Å c=12.453(2)Å
α=80.499(3)° β=62.449(2)° γ=75.937(2)°
6(4)-O-CAMPHORSULFONYL 2,4(6)DIBENZOYL MYO-INOSITOL 1,3,5 ORTHOFORMATE
C31H32O11S
Crystal Growth & Design (2005) 5, 3 833
a=14.115(3)Å b=11.592(3)Å c=17.743(4)Å
α=90.00° β=92.529(4)° γ=90.00°
6(4)-O-CAMPHORSULPHONYL 2,4(6)DIBENZOYL MYO-INOSITOL 1,3,5 ORTHOFORMATE
C31H32O11S,1.375(CH2Cl2)
Crystal Growth & Design (2005) 5, 3 833
a=30.561(17)Å b=10.925(6)Å c=22.255(12)Å
α=90.00° β=114.922(10)° γ=90.00°
6(4)-O-CAMPHORSULPHONYL 2,4(6)DIBENZOYL MYO-INOSITOL 1,3,5 ORTHOFORMATE
C31H32O11S,0.75(C6H6)
Crystal Growth & Design (2005) 5, 3 833
a=31.182(4)Å b=11.2219(13)Å c=22.715(3)Å
α=90.00° β=109.948(2)° γ=90.00°
6(4)-O-CAMPHORSULPHONYL 2,4(6)DIBENZOYL MYO-INOSITOL 1,3,5 ORTHOFORMATE
C31H32O11S,0.5(C6H10O),0.5(C6H12)
Crystal Growth & Design (2005) 5, 3 833
a=31.047(6)Å b=11.2665(18)Å c=22.631(4)Å
α=90.00° β=109.880(4)° γ=90.00°
6(4)-O-CAMPHORSULPHONYL 2,4(6)DIBENZOYL MYO-INOSITOL 1,3,5 ORTHOFORMATE
C31H32O11S,1.38(C4H8O2)
Crystal Growth & Design (2005) 5, 3 833
a=15.937(4)Å b=11.054(3)Å c=22.206(6)Å
α=90.00° β=108.432(4)° γ=90.00°
6(4)-O-CAMPHORSULPHONYL 2,4(6)DIBENZOYL MYO-INOSITOL 1,3,5 ORTHOFORMATE
C31H32O11S,1.35(C5H5N),0.38(H2O)
Crystal Growth & Design (2005) 5, 3 833
a=30.623(9)Å b=11.129(4)Å c=22.529(7)Å
α=90.00° β=111.050(5)° γ=90.00°
6(4)-O-CAMPHORSULFONYL 2,4(6)DIBENZOYL MYO-INOSITOL 1,3,5 ORTHOFORMATE
C31H32O11S
Crystal Growth & Design (2006) 6, 6 1485
a=14.115(3)Å b=11.592(3)Å c=17.743(4)Å
α=90.00° β=92.529(4)° γ=90.00°
6(4)-O-CAMPHORSULPHONYL 2,4(6)DIBENZOYL MYO-INOSITOL 1,3,5 ORTHOFORMATE
C31H32O11S,1.375(CH2Cl2)
Crystal Growth & Design (2006) 6, 6 1485
a=30.561(17)Å b=10.925(6)Å c=22.255(12)Å
α=90.00° β=114.922(10)° γ=90.00°
6(4)-O-CAMPHORSULPHONYL 2,4(6)DIBENZOYL MYO-INOSITOL 1,3,5 ORTHOFORMATE
C31H32O11S,1(C4H8O2),0.75(C5H5N)
Crystal Growth & Design (2006) 6, 6 1485
a=30.896(3)Å b=10.9667(11)Å c=22.408(2)Å
α=90.00° β=111.469(2)° γ=90.00°
6(4)-O-CAMPHORSULPHONYL 2,4(6)DIBENZOYL MYO-INOSITOL 1,3,5 ORTHOFORMATE
C31H32O11S,1(C4H8O2),0.25(C4H8O)
Crystal Growth & Design (2006) 6, 6 1485
a=15.966(3)Å b=11.068(3)Å c=22.264(5)Å
α=90.00° β=108.676(4)° γ=90.00°
6(4)-O-CAMPHORSULPHONYL 2,4(6)DIBENZOYL MYO-INOSITOL 1,3,5 ORTHOFORMATE
C31H32O11S,0.5(C6H10O),0.5(C6H12)
Crystal Growth & Design (2006) 6, 6 1485
a=31.047(6)Å b=11.2665(18)Å c=22.631(4)Å
α=90.00° β=109.880(4)° γ=90.00°
6(4)-O-CAMPHORSULPHONYL 2,4(6)DIBENZOYL MYO-INOSITOL 1,3,5 ORTHOFORMATE
C31H32O11S,0.75(C6H6)
Crystal Growth & Design (2006) 6, 6 1485
a=31.182(4)Å b=11.2219(13)Å c=22.715(3)Å
α=90.00° β=109.948(2)° γ=90.00°
6(4)-O-CAMPHORSULPHONYL 2,4(6)DIBENZOYL MYO-INOSITOL 1,3,5 ORTHOFORMATE
C31H32O11S,1.35(C5H5N),0.38(H2O)
Crystal Growth & Design (2006) 6, 6 1485
a=30.623(9)Å b=11.129(4)Å c=22.529(7)Å
α=90.00° β=111.050(5)° γ=90.00°
6(4)-O-CAMPHORSULPHONYL 2,4(6)DIBENZOYL MYO-INOSITOL 1,3,5 ORTHOFORMATE
C31H32O11S,1.325(C4H8O)
Crystal Growth & Design (2006) 6, 6 1485
a=30.675(6)Å b=11.218(2)Å c=22.323(5)Å
α=90.00° β=113.729(6)° γ=90.00°
6(4)-O-CAMPHORSULPHONYL 2,4(6)DIBENZOYL MYO-INOSITOL 1,3,5 ORTHOFORMATE
C31H32O11S,1.38(C4H8O2)
Crystal Growth & Design (2006) 6, 6 1485
a=15.937(4)Å b=11.054(3)Å c=22.206(6)Å
α=90.00° β=108.432(4)° γ=90.00°